The second round of Seed Funding opened for competitive applications on 18 January 2019 and closed on 15 April 2019. Eighteen applications were received, they were reviewed by the working group on 04 June 2019.  The working group recommended that give applications be funded and this was ratified by the Board at their meeting on 11 July 2019.

Total grant funding awarded in Round 2 Seed Funding was $381,982.83.

MethAmphetamine use in young people: Sub-anaesthetic ketamine open-label trial; MASKOT

Amount awarded: $99,703.00

Principal Investigator: Dr Gill Bedi, Orygen.

Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways

Amount awarded: $77,489.00

Principal Investigator: A/Prof Peter Kelly, University of Wollongong.

A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder

Amount awarded: $97,595.00

Principal Investigator: A/Prof Victoria Manning, Monash University

Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips

Amount awarded: $38,795.00

Principal Investigator: Dr Rachel Sutherland, University of New South Wales.

An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings

Amount awarded: $68,400.00

Principal Investigator: A/Prof James Ward, South Australian Health and Medical Research Institute.